Efficacy of intravenous fosfomycin in complicated urinary tract infection with real-life conditions. Impact of MIC and baseline mutations. FOSFO-MIC project
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: PUBLIC ANDALUSIAN FOUNDATION FOR THE MANAGEMENT OF HEALTH RESEARCH IN SEVILLE
- Execution start: 31/01/2020
- End of execution: 30/03/2021
- IP: DAVID VINUESA GARCIA